Ignite Creation Date:
2024-05-06 @ 9:23 AM
Last Modification Date:
2024-10-26 @ 12:13 PM
Study NCT ID:
NCT02960230
Status:
COMPLETED
Last Update Posted:
2024-02-22
First Post:
2016-11-02
Brief Title:
H33K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
Sponsor:
Sabine Mueller MD PhD
Organization:
University of California San Francisco
Organization Data
Organization:
University of California San Francisco
Class:
OTHER
Study ID:
PNOC 007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sabine Mueller MD PhD
Lead Sponsor Class:
OTHER
Responsible Party:
Sabine Mueller MD PhD
Responsible Party Title:
Associate Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of California San Francisco
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |
| The V Foundation for Cancer Research | OTHER |
| Pacific Pediatric Neuro-Oncology Consortium | OTHER |